Want to see HK:2591 full AI Analyst Report?
Earnings Data
Report Date
―Before Open (Confirmed)
Period Ending
―Consensus EPS Forecast
―Last Year’s EPS
―Same Quarter Last Year
Moderate Buy
Based on 1 Analysts Ratings
Guangzhou Innogen Pharmaceutical Group Co Ltd Class H (HK:2591) Earnings, Revenues Date & History
HK:2591 Q2 2026 Earnings Report
HK:2591 Earnings History
Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release | Slides | Play Transcript |
|---|---|---|---|---|---|---|---|
| 2026 (Q2) | -0.365 | 20.13% (+0.07) | ― | ― | |||
| 2025 (Q4) | -0.236 | -122.46% (-0.29) | ― | ― | |||
| 2025 (Q2) | -0.179 | -74.86% (-0.13) | ― | ― |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
FAQ
When does Guangzhou Innogen Pharmaceutical Group Co Ltd Class H (HK:2591) report earnings?
Currently, no data Available
What is Guangzhou Innogen Pharmaceutical Group Co Ltd Class H (HK:2591) earnings time?
Currently, no data Available
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is the P/E ratio of Guangzhou Innogen Pharmaceutical Group Co Ltd Class H stock?
The P/E ratio of Guangzhou Innogen Pharmaceutical Group Co Ltd Class H is N/A.
What is HK:2591 EPS forecast?
Currently, no data Available